These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3560789)

  • 21. Secondary oxalosis as a complication of parenteral alimentation in acute renal failure.
    Friedman AL; Chesney RW; Gilbert EF; Gilchrist KW; Latorraca R; Segar WE
    Am J Nephrol; 1983; 3(5):248-52. PubMed ID: 6416068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiorgan crystal deposition following intravenous oxalate infusion in rat.
    Blumenfrucht MJ; Cheeks C; Wedeen RP
    J Urol; 1986 Jun; 135(6):1274-9. PubMed ID: 3712586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroidectomy. Treatment for secondary hyperparathyroidism and azotemic osteodystrophy.
    Berens JJ; Potter DJ; Nickas GM
    Arch Surg; 1970 Apr; 100(4):338-42. PubMed ID: 5417157
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Problem of adaptive hyperparathyroidism in chronic renal failure].
    Weiland P; Hagenberg C
    Z Gesamte Inn Med; 1983 Jan; 38(2):50-3. PubMed ID: 6858271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of oxalosis with heart and lung involvement].
    Magnani G; Fatone F; Martella D; Binetti G; Magnani B
    Cardiologia; 1992 Jul; 37(7):507-11. PubMed ID: 8521429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extensive calcification of the muscles caused by secondary hyperparathyroidism in a patient with terminal renal failure, treated by repeated hemodialysis and parathyroidectomy].
    Hanicki Z; Smoleński O; Sułowicz W; Kopeć J
    Przegl Lek; 1983; 40(7):593-7. PubMed ID: 6635256
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oxalic acid--important uremic toxin].
    Mydlík M; Derzsiová K
    Vnitr Lek; 2010 Jul; 56(7):695-701. PubMed ID: 20842915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxalic acid excretion after intravenous ascorbic acid administration.
    Robitaille L; Mamer OA; Miller WH; Levine M; Assouline S; Melnychuk D; Rousseau C; Hoffer LJ
    Metabolism; 2009 Feb; 58(2):263-9. PubMed ID: 19154961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in the anemia of hemodialyzed patients following subtotal parathyroidectomy. Evidence for the role of secondary hyperparathyroidism in the etiology of the anemia of chronic renal failure.
    Shasha SM; Better OS; Winaver J; Chaimovitz C; Barzilai A; Erlik D
    Isr J Med Sci; 1978 Mar; 14(3):328-32. PubMed ID: 640816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
    Ahmad S; Hatch M
    Nephron; 1985; 41(3):235-40. PubMed ID: 4058624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive specifically localized myocardial calcium deposition in a hemodialysis patient.
    Yanagi S; Teragaki M; Tahara A; Itagane H; Akioka K; Yasuda M; Oku H; Takeuchi K; Takeda T; Ueda M
    Jpn Circ J; 1992 Jan; 56(1):27-31. PubMed ID: 1538574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arthritis associated with calcium oxalate crystals in an anephric patient treated with peritoneal dialysis.
    Rosenthal A; Ryan LM; McCarty DJ
    JAMA; 1988 Sep; 260(9):1280-2. PubMed ID: 3404640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Macroscopic cardiac calcifications and other calcium metastases in a patient on chronic hemodialysis].
    Fendler JP; Baviéra E; Baglin A; Veillon B; Gaux JC; Bergue A; Mignot J; Fritel D
    Ann Med Interne (Paris); 1973 Nov; 124(11):799-806. PubMed ID: 4792232
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute kidney failure in secondary renal oxalosis. Additional indications for a causal connection to xylitol infusions].
    Schultze G; Pommer W; Offermann G; Molzahn M; Butz M; Krause PH; Lobeck H; Tschöpe W
    Infusionsther Klin Ernahr; 1983 Dec; 10(6):322-8. PubMed ID: 6420342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of tumoral calcinosis after the appropriate control of a deranged mineral and bone metabolism, in conjugation with cinacalcet hydrochloride treatment, in a chronic hemodialysis patient.
    Yamada S; Tsuruya K; Kitazono T
    Ther Apher Dial; 2013 Jun; 17(3):348-9. PubMed ID: 23735152
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
    Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
    Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary oxalosis mimicking hyperparathyroidism diagnosed after long-term hemodialysis.
    Canavese C; Salomone M; Massara C; Portigliatti Barbos M; Cadario A; Pavan I; Marangella M; Petrarulo M; Rotolo U
    Am J Nephrol; 1990; 10(4):344-9. PubMed ID: 2240064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
    Pru C; Eaton J; Kjellstrand C
    Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
    Meakins JL; Milne CA; Hollomby DJ; Goltzman D
    Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.